Home > Investor Information


Investor Information

Vyteris Expands Scientific Advisory Board With Four New Appointments 07.13.10

FAIR LAWN, NJ, Jul 13, 2010 (MARKETWIRE via COMTEX News Network) -- Vyteris, Inc. (OTCBB: VYTR), manufacturer of the first FDA-approved active patch transdermal drug delivery system, and a leader in active transdermal drug delivery technology, today announced the appointment of four new members to its Scientific Advisory Board (SAB). The new appoin...

Vyteris to Present at OneMedForum New York 2010 06.25.10

FAIR LAWN, NJ, Jun 25, 2010 (MARKETWIRE via COMTEX News Network) -- Vyteris, Inc. (OTCBB: VYTR), manufacturer of the first FDA-approved active patch transdermal drug delivery system and a leader in active transdermal drug delivery technology, today announced that President and Chief Executive Officer Haro Hartounian, Ph.D. will present at OneMedFor...


Financial Results

quarterly report    10-Q    05.14.10
annual report    10-K    03.25.10
quarterly report    10-Q    11.13.09

Delayed 20 minutes.
Last Trade: 0.44
Change: + 0.18
% Change: + 69.231%
Intraday Range: 0.30 - 0.44
Jul 29, 2010 2:28 PM ET
Stock Information >>

2008 Annual Report Download Center
May 17, 2009
2009 Proxy Statement Download Center
May 21, 2009
©2010 Vyteris, Inc. | Privacy Policy